Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A growing family: adding mutated Erbb4 as a novel cancer target.

Cell cycle (Georgetown, Tex.) - 15 Apr 2010

Rudloff Udo, Samuels Yardena

Abstract excerpt

As the upward spiral of novel cancer gene discoveries and novel molecular compounds continues to accelerate, a repetitive theme in molecular drug development remains the lack of activity of initially promising agents when given to patients in clinical trials. It is however invigorating that a few targeted agents directed against a select group of a few 'cancer gene superfamilies' have escaped this all to common...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ErbB Receptors
Share to Ligands
Share to Melanoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precision Medicine

Share to Protein Kinase Inhibitors

Share to Protein-Tyrosine Kinases

Share to Receptor, ErbB-4

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 20404484
DOI: 10.4161/cc.9.8.11239
PMCID: PMC3384517

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A growing family: adding mutated Erbb4 as a novel cancer target.PMID 20404484Read ↗

Mutated ERBB4: a novel drug target in metastatic melanoma?Semantic proximity Read ↗

A therapeutic opportunity in melanoma: ErbB4 makes a mark on skin.Semantic proximity Read ↗

Somatic mutations of ErbB4: selective loss-of-function phenotype affecting signal transduction pathways in cancer.Semantic proximity Read ↗

Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.Semantic proximity Read ↗

ERBB4 Drives the Proliferation of BRAF-WT Melanoma Cell LinesSemantic proximity Read ↗

Emergence of ERBB2 Mutation as a Biomarker and an Actionable Target in Solid CancersSemantic proximity Read ↗

<i>ERBB4</i>Mutant Alleles Found in<i>BRAF</i>WT Melanomas That Drive the Proliferation of a<i>BRAF</i>WT Melanoma Cell LineSemantic proximity Read ↗

HER family in cancer progression: From discovery to 2020 and beyond.Semantic proximity Read ↗

Targeting ErbB receptor signaling: A pan-ErbB approach to cancerSemantic proximity Read ↗

An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations.Semantic proximity Read ↗

ErbB receptors: from oncogenes to targeted cancer therapiesSemantic proximity Read ↗

Thirty Years of HER3: From Basic Biology to Therapeutic InterventionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.